FAMI on Nasdaq
Farmmi, Inc.
Canned company that raised $10 million in 2025 (SEC Form D). Summary from the record
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with Seneca Foods, The J.M. Smucker Company or BARFRESH FOOD GROUP INC., or pick any stock.
- TickerFAMI on Nasdaq1
- IndustryCanned, Fruits, Veg, Preserves, Jams & Jellies1
- HeadquartersZhejiang Province, China1
- Incorporated inCayman Islands3
- Business addressFl 1, Building No. 1, 888 Tianning Street, Liandu District, Lishui, Zhejiang Province, F4 3230003
- Filer categoryNon-accelerated filer3
- Legal formCorporation
See how the biggest companies compare on our leaderboards
Farmmi, Inc. (“FAMI”), is a Cayman Islands holding company incorporated on July 28, 2015. We conduct our operations in China principally through our foreign-owned PRC subsidiaries. FAMI’s registered office is at the office of Sertus Incorporations (Cayman) Limited, Sertus Chambers, Governors Square, Suite # 5-204, 23 Lime Tree Bay Avenue, P.O. Box 2547, Grand Cayman, KY1-1104, Cayman Islands. Its registered office’s telephone number is +1.345.745.5100. Farmmi, Inc.’s agent in the U.S. is Shangzhi Zhang, with the address of 33202 Havers Drive, Cary, NC 27518.4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
2.9%Gross margin2
-200.6%Operating margin2
-189.8%Net margin2
-56.4%Revenue growth, 20252
-42.8%Return on equity2
0.01×Debt to equity2
$52.4MFree cash flow2
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue97¢$27.2M
- Other costs3¢$801.5K
- Income tax0¢$42
Out of $28.0M in revenue.2 The company lost money this year.
Where each dollar of operating cash went, fiscal 2025
- Capital spending0¢$16.7K
- Kept or used elsewhere100¢$52.4M
Out of $52.5M of cash from operations.2
Financial statements
No quarterly figures reported.
Every line of the income statement as filed: the last 3 fiscal years, latest first.2
| Period ending | 2025-09-30 | 2024-09-30 | 2023-09-30 |
|---|---|---|---|
| Sales to third parties | $28.0M | $64.1M | $110.4M |
| Sales to related parties | $138 | $2.8K | $0 |
| Revenues | $28.0M | $64.1M | $110.4M |
| Cost of revenues | -$27.2M | -$60.3M | -$106.1M |
| Gross profit | $801.5K | $3.9M | $4.3M |
| Impairment loss for biological assets | -$8.9M | $0 | $0 |
| (Allowance) reversal of allowance for credit losses | -$45.1M | -$418.7K | $32.0K |
| Selling and distribution expenses | -$309.1K | -$135.8K | -$145.3K |
| General and administrative expenses | -$2.6M | -$2.5M | -$2.1M |
| Total operating expenses | -$56.9M | -$3.1M | -$2.2M |
| (Loss) income from operations | -$56.1M | $795.7K | $2.0M |
| Change in fair value of derivative liability | $0 | $0 | $873.8K |
| Interest income | $10.5K | $3.9K | $743.9K |
| Interest expense | -$418.3K | -$1.7M | -$650.8K |
| Amortization of debt issuance costs | -$294.7K | -$60.3K | -$1.7M |
| Government grant | $9.3K | $0 | $1.4M |
| Other income, net | $1.5M | $265.4K | $101.5K |
| Gain (loss) on disposal of subsidiaries | $1.9M | -$3.9M | $0 |
| Total other income (expenses), net | $2.7M | -$5.4M | $815.9K |
| (Loss) income before income taxes | -$53.4M | -$4.6M | $2.9M |
| Income tax expense | -$42 | -$264 | -$313.5K |
| Net (loss) income | -$53.4M | -$4.6M | $2.5M |
| Less: Net (loss) income attributable to non-controlling interest | -$287.3K | $26.9K | $0 |
| Net (loss) income attributable to Farmmi, Inc. | -$53.1M | -$4.7M | $2.5M |
| Net (loss) income | -$53.1M | -$4.7M | $2.5M |
| Foreign currency translation | -$3.6M | $10.8M | -$4.3M |
| Comprehensive (loss) income attributable to Farmmi, Inc | -$56.7M | $6.1M | -$1.7M |
| Basic | 1.8M shares | 590.7K shares | 302.4K shares |
| Diluted | 1.8M shares | 590.7K shares | 704.4K shares |
| Basic. | -$28.92 | -$7.88 | $8.41 |
| Diluted. | -$28.92 | -$7.88 | $3.61 |
No quarter-by-quarter statement was filed.
No quarterly figures reported.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.2
| Period ending | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Cash and restricted cash | $804.1K | $486.5K | $12.8M | $41.2M |
| Accounts receivable, net | $13.1M | $32.5M | ||
| Advances to suppliers, net | $46.3M | $122.1M | ||
| Note receivable, current portion | $31.0M | $0 | ||
| Inventories, net | $1.5M | $5.5M | ||
| Other current assets, net | $372.3K | $1.0M | ||
| Due from a related party | $0 | $312.4K | ||
| Total current assets | $93.1M | $161.9M | ||
| Note receivable | $28.6M | $0 | ||
| Long-term investments, net | $6.9M | $7.0M | ||
| Biological assets, net | $0 | $9.3M | ||
| Right-of-use assets, net | $16.4M | $7.4M | ||
| Security deposits | $1.9M | $0 | ||
| Property and equipment, net | $36.8K | $42.3K | ||
| Other non-current assets | $0 | $1.0M | ||
| Total non-current assets | $53.9M | $24.8M | ||
| Total assets | $147.0M | $186.7M | ||
| Long-term loans - current | $0 | $202.4K | ||
| Promissory notes | $2.5M | $5.3M | ||
| Accounts payable | $15.7K | $70.0K | ||
| Due to related parties | $293.9K | $501.5K | ||
| Operating lease liabilities - current | $5.0M | $3.4M | ||
| Other current liabilities | $2.1M | $639.0K | ||
| Total current liabilities | $10.0M | $10.1M | ||
| Long-term loans - non-current | $1.8M | $2.2M | ||
| Operating lease liabilities - non-current | $11.4M | $4.0M | ||
| Other non-current liabilities | $0 | $454.0K | ||
| Total non-current liabilities | $13.2M | $6.7M | ||
| Total liabilities | $23.2M | $16.7M | ||
| Ordinary shares, $2.40 par value, 5 billion shares authorized, 5,481,874 and 889,906 shares issued and outstanding as of September 30, 2025 and 2024, respectively | $13.2M | $2.1M | ||
| Additional paid-in capital | $161.4M | $161.6M | ||
| Statutory reserve | $687.2K | $697.4K | ||
| (Accumulated deficit) Retained earnings | -$39.8M | $13.2M | ||
| Accumulated other comprehensive loss | -$11.3M | -$7.7M | ||
| Total Farmmi, Inc.'s shareholders' equity | $124.1M | $170.0M | ||
| Noncontrolling interest | -$260.4K | $26.9K | ||
| Total shareholders' equity | $123.9M | $170.0M | $162.0M | $154.7M |
| Total liabilities and shareholders' equity | $147.0M | $186.7M | ||
| Ordinary shares, par value | $2.40 | $2.40 | ||
| Ordinary share, shares authorized | 5.0B shares | 5.0B shares | ||
| Ordinary share, shares issued | 5.5M shares | 889.9K shares | ||
| Ordinary share, shares outstanding | 5.5M shares | 889.9K shares |
| Period ending | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Cash and restricted cash | $804.1K | $486.5K | $12.8M | $41.2M |
| Accounts receivable, net | $13.1M | $32.5M | ||
| Advances to suppliers, net | $46.3M | $122.1M | ||
| Note receivable, current portion | $31.0M | $0 | ||
| Inventories, net | $1.5M | $5.5M | ||
| Other current assets, net | $372.3K | $1.0M | ||
| Due from a related party | $0 | $312.4K | ||
| Total current assets | $93.1M | $161.9M | ||
| Note receivable | $28.6M | $0 | ||
| Long-term investments, net | $6.9M | $7.0M | ||
| Biological assets, net | $0 | $9.3M | ||
| Right-of-use assets, net | $16.4M | $7.4M | ||
| Security deposits | $1.9M | $0 | ||
| Property and equipment, net | $36.8K | $42.3K | ||
| Other non-current assets | $0 | $1.0M | ||
| Total non-current assets | $53.9M | $24.8M | ||
| Total assets | $147.0M | $186.7M | ||
| Long-term loans - current | $0 | $202.4K | ||
| Promissory notes | $2.5M | $5.3M | ||
| Accounts payable | $15.7K | $70.0K | ||
| Due to related parties | $293.9K | $501.5K | ||
| Operating lease liabilities - current | $5.0M | $3.4M | ||
| Other current liabilities | $2.1M | $639.0K | ||
| Total current liabilities | $10.0M | $10.1M | ||
| Long-term loans - non-current | $1.8M | $2.2M | ||
| Operating lease liabilities - non-current | $11.4M | $4.0M | ||
| Other non-current liabilities | $0 | $454.0K | ||
| Total non-current liabilities | $13.2M | $6.7M | ||
| Total liabilities | $23.2M | $16.7M | ||
| Ordinary shares, $2.40 par value, 5 billion shares authorized, 5,481,874 and 889,906 shares issued and outstanding as of September 30, 2025 and 2024, respectively | $13.2M | $2.1M | ||
| Additional paid-in capital | $161.4M | $161.6M | ||
| Statutory reserve | $687.2K | $697.4K | ||
| (Accumulated deficit) Retained earnings | -$39.8M | $13.2M | ||
| Accumulated other comprehensive loss | -$11.3M | -$7.7M | ||
| Total Farmmi, Inc.'s shareholders' equity | $124.1M | $170.0M | ||
| Noncontrolling interest | -$260.4K | $26.9K | ||
| Total shareholders' equity | $123.9M | $170.0M | $162.0M | $154.7M |
| Total liabilities and shareholders' equity | $147.0M | $186.7M | ||
| Ordinary shares, par value | $2.40 | $2.40 | ||
| Ordinary share, shares authorized | 5.0B shares | 5.0B shares | ||
| Ordinary share, shares issued | 5.5M shares | 889.9K shares | ||
| Ordinary share, shares outstanding | 5.5M shares | 889.9K shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.2
| Period ending | 2025-09-30 | 2024-09-30 | 2023-09-30 |
|---|---|---|---|
| Net (loss) income | -$53.4M | -$4.6M | $2.5M |
| Changes in allowances - accounts receivable | $34.4M | $280.2K | $7.9K |
| Changes in allowances - advances to suppliers | $10.0M | -$3.2K | $0 |
| Changes in allowances - inventories | -$8.1K | $3.9K | -$41.0K |
| Changes in allowances - other current assets | $676.5K | $0 | $0 |
| Changes in allowances - due from related parties | $96.8K | $0 | $0 |
| Changes in allowances - long-term investment | $0 | $137.8K | $92.9K |
| Changes in impairment - biological assets | $8.9M | $0 | $0 |
| Depreciation | $14.4K | $11.1K | $26.9K |
| Amortization of operating lease right-of-use assets | $3.1M | $364.3K | $45.5K |
| Loss on short-term investment | $0 | $0 | $5.9K |
| Loss on disposal of property and equipment | $0 | $0 | $124 |
| (Gain) (loss) from disposal of subsidiaries | -$1.9M | $3.9M | -$5.6K |
| Amortization of debt issuance costs | $294.7K | $60.3K | $1.7M |
| Interest expenses for promissory note redemption | $94.2K | $1.4M | $0 |
| Amortization of biological assets | $212.4K | $213.2K | $217.2K |
| Deferred income tax provision | $0 | $0 | $164.6K |
| Change in fair value of derivative liability | $0 | $0 | -$873.8K |
| Accounts receivable, net | -$16.0M | -$10.6M | -$9.0M |
| Advances to suppliers, net | $62.8M | -$9.3M | -$71.3M |
| Note receivable | $0 | $0 | $3.6M |
| Inventories, net | $3.7M | -$1.4M | -$3.3M |
| Other current assets | $1.2M | -$318.1K | -$222.4K |
| Other non-current assets - security deposits | -$877.3K | -$1.0M | $0 |
| Accounts payable | $841.7K | $3.0M | $946.3K |
| Operating lease liabilities | -$3.1M | -$359.2K | -$63.5K |
| Other current liabilities | $1.4M | $937.3K | -$232.5K |
| Other non-current liabilities | $0 | $454.0K | $0 |
| Net cash provided by (used in) operating activities | $52.5M | -$16.8M | -$75.8M |
| Purchase of property and equipment | -$16.7K | -$29.4K | -$314 |
| Short-term deposits | $0 | $0 | $35.4M |
| Proceeds from disposal of subsidiaries, net of cash | -$60.5K | $2.1M | $13.0K |
| Cash paid for investment | -$59.6M | $0 | -$7.1M |
| Other receivables | $0 | $0 | $7.5M |
| Advances to related parties | $0 | $0 | -$7.1K |
| Repayment of advances to related party | $0 | $0 | $30.9K |
| Net cash (used in) provided by investing activities | -$59.7M | $2.1M | $35.9M |
| Proceeds from promissory notes | $0 | $5.0M | $0 |
| Repayment of promissory notes | -$2.6M | -$130.0K | $0 |
| Repayment of convertible promissory notes | $0 | -$6.1M | $0 |
| Borrowings from a third party loan | $4.4M | $2.2M | $0 |
| Repayment of a third party loan | -$4.8M | -$7.0K | $0 |
| Repayment of bank acceptance notes payable | $0 | $0 | -$12.5K |
| Proceed from issuance of ordinary shares for warrants exercised | $782.0K | $0 | $0 |
| Proceed from issuance of ordinary shares, net | $9.8M | $762.7K | $7.9M |
| Borrowing from bank loans | $0 | $0 | $4.8M |
| Repayments of bank loans | $0 | -$164.7K | -$1.7M |
| Repayment of advances from related parties | -$115.2K | -$482.8K | $0 |
| Proceeds from advances from related parties | $0 | $715.2K | $9.2K |
| Net cash provided by (used in) financing activities | $7.6M | $1.8M | $11.0M |
| Effect of exchange rate changes on cash | -$3.5K | $576.6K | $462.3K |
| Net increase (decrease) in cash | $317.6K | -$12.3M | -$28.4M |
| Cash, end of year | $803.5K | $486.5K | $12.8M |
| Restricted cash, end of year | $621 | $0 | $0 |
| Total cash and restricted cash, end of year | $804.1K | $486.5K | $12.8M |
| Income taxes paid | $0 | $1.2K | $67.6K |
| Interest paid | $288.4K | $65.6K | $165.2K |
| Note receivable for refund due from cancelled investment | $59.6M | $0 | $0 |
| Right-of-use assets obtained in exchange for operating lease obligations | $13.2M | $7.3M | $2.9K |
| Issuance of ordinary shares for promissory notes redemption | $244.3K | $1.2M | $1.1M |
| Interest expenses for promissory note redemption | $94.2K | $1.3M | $1.7M |
No quarter-by-quarter statement was filed.
Leadership
Who has led Farmmi, Inc., and when. Pick a name to see everywhere that person has worked.
- Chief executive officerYefang Zhang Mar 17, 2026 to now11
- Chief financial officerZhimin Lu Mar 31, 2026 to now12
Board members and other officers (5)
- Board memberChenyang Wang Mar 17, 2026 to now13
- Board memberYefang Zhang Mar 17, 2026 to now11
- Board memberHongdao Qian Mar 31, 2026 to now14
- Board memberHui Ruan Mar 31, 2026 to now15
- Board memberQinyi Fu Mar 31, 2026 to now16
Timeline
- Mar 17, 2026New chief executive Yefang Zhang becomes CEO11
Filings
111 filings to the SEC since October 2021: 5 annual reports, 6 insider forms, 4 large holders, 1 private raises, 95 other. The latest 20:
- Aug 27, 20266-K EDGAR
- Aug 14, 2026SCHEDULE 13G/A EDGAR
- Aug 12, 20266-K EDGAR
- Jul 6, 20266-K EDGAR
- Jul 6, 2026SCHEDULE 13G EDGAR
- Jun 30, 2026424B5 EDGAR
- Jun 29, 2026424B5 EDGAR
- Jun 22, 20266-K EDGAR
- Jun 17, 2026424B5 EDGAR
- May 29, 20266-K EDGAR
- May 6, 20266-K EDGAR
- Apr 10, 20266-K EDGAR
- Mar 31, 20263 EDGAR
- Mar 31, 20263 EDGAR
- Mar 31, 20263 EDGAR
- Mar 31, 20263 EDGAR
- Mar 17, 20263 EDGAR
- Mar 17, 20263 EDGAR
- Feb 25, 20266-K EDGAR
- Feb 10, 202620-F EDGAR
The 111 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- S.H.N. Financial Investments Ltd.SCHEDULE 13G/A, 2 filings Jul 6, 2026 to Aug 14, 202617
- INTRACOASTAL CAPITAL, LLCSC 13G, 1 filing Aug 30, 202418
- SABBY MANAGEMENT, LLCSC 13G/A, 1 filing Jan 4, 202219
Money raised
Private offerings the company reported to the SEC on Form D.
- Aug 4, 2025Raised $10 million in a private offering of securities Form D: 12 investors so far Form D
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARFarmmi, Inc. filings on SEC EDGAR
- 2SEC EDGARFarmmi, Inc. 10-K for fiscal 2025
- 3SEC EDGARFarmmi, Inc. filings on SEC EDGAR
- 4
- 5SEC EDGARFarmmi, Inc. 10-K for fiscal 2018
- 6SEC EDGARFarmmi, Inc. 10-K for fiscal 2019
- 7SEC EDGARFarmmi, Inc. 10-K for fiscal 2021
- 8SEC EDGARFarmmi, Inc. 10-K for fiscal 2022
- 9SEC EDGARFarmmi, Inc. 10-K for fiscal 2020
- 10SEC EDGARFarmmi, Inc. 10-K for fiscal 2018
- 11
- 12SEC EDGARZhimin Lu, Chief financial officer
- 13SEC EDGARChenyang Wang, Board member
- 14SEC EDGARHongdao Qian, Board member
- 15SEC EDGARHui Ruan, Board member
- 16SEC EDGARQinyi Fu, Board member
- 17
- 18
- 19